Effects of vedolizumab, adalimumab and infliximab on biliary inflammation in individuals with primary sclerosing cholangitis and inflammatory bowel disease

Alimentary Pharmacology&Therapeutics, EarlyView.

Source: Alimentary Pharmacology and Therapeutics - May 29, 2018 Category: Drugs & Pharmacology Authors: C. S. Tse , E. V. Loftus Jr , L. E. Raffals , A. A. Gossard , A. L. Lightner Source Type: research